Scientific Evidence for the Use of Homeopathy for the Prevention and Treatment of COVID-19

Resumo

As of November 2, 2022, according to the World Health Organization (WHO), the total number of confirmed cases of COVID-19 in the world passed 620 million, and the total number of deaths due to the infection passed 6.5 million. Today, specific drugs against SARS-CoV-2 are still under study or starting to be marketed. In contrast, homeopathy is a long-established medical rationale, and is based on the patient's symptoms and individuality when choosing a medicine. Thus, the aim of this literature review was to gather available scientific evidence on the effectiveness of homeopathy in the prevention or treatment of COVID-19. We found 3 randomized clinical trial articles, 1 cohort study, and 7 descriptive observational studies. Of these, 73% repertorized the patients' symptoms and the prescription was individualized. The remaining articles were concerned with the analysis of homeopathic medicines as epidemic genius. Compiling the findings, it could be observed that homeopathy does indeed have a high beneficial adjuvant potential in the treatment of COVID-19 in mild, moderate and severe cases of the disease. However, more robust clinical trials and cohort studies are needed to investigate the prophylactic power of homeopathy in this case. Furthermore, Arsenicum album and Bryonia alba were the most prescribed drugs, with better results both in prevention and adjuvant treatment to allopathy, and therefore, are the ones suggested in this study as the epidemic genie.

DOI: https://doi.org/10.56238/colleinternhealthscienv1-077